Allurion Technologies (ALUR) Net Margin (2022 - 2026)
Allurion Technologies (ALUR) posted Net Margin of 206.82% for Q1 2026, down 18.97% on a QoQ basis from 173.84% in Q4 2025, and down 33906.0% year-over-year from N/an in Q1 2025.
Allurion Technologies (ALUR) Net Margin (2022 - 2026) Analysis & Trends
Allurion Technologies' Net Margin history runs 5 years deep, the most recent figure standing at 206.82% for Q1 2026.
- Quarterly Net Margin fell 33906.0% year-over-year to 206.82% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 266.69% (down 26028.0% YoY) and the FY2025 annual result came in at 190.11%, down 16769.0% from the prior year.
- Net Margin was 206.82% for Q1 2026 at Allurion Technologies, down from 173.84% in the prior quarter.
- Across five years, Net Margin topped out at 162.77% in Q3 2024 and bottomed at 447.1% in Q3 2025.
- A 5-year average of 119.51% and a median of 125.93% in 2023 frame the typical range for Net Margin.
- Annual changes were most pronounced in 2024 — Net Margin surged 28302 bps — and 2025, when it plunged 60988 bps.
- Allurion Technologies' Net Margin stood at 68.18% in 2022, then plunged by 281 bps to 259.74% in 2023, then surged by 34 bps to 171.85% in 2024, then dropped by 1 bps to 173.84% in 2025, then slipped by 19 bps to 206.82% in 2026.
- Business Quant data shows ALUR's Net Margin at 206.82% in Q1 2026, 173.84% in Q4 2025, and 447.1% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 9.65% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 12.38% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 12.84% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 25.77% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 16.74% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 3.87% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 8.01% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Allurion Technologies | 74.67 Mn | 69.62 Mn | 1.23 Mn | -206.82% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -206.82% |
| Dec 31, 2025 | -173.84% |
| Sep 30, 2025 | -447.10% |
| Jun 30, 2025 | -276.27% |
| Mar 31, 2025 | 132.24% |
| Dec 31, 2024 | -171.85% |
| Sep 30, 2024 | 162.77% |
| Jun 30, 2024 | -70.73% |
| Mar 31, 2024 | 21.27% |
| Dec 31, 2023 | -259.74% |
| Sep 30, 2023 | -120.25% |
| Jun 30, 2023 | -175.32% |
| Mar 31, 2023 | -131.60% |
| Dec 31, 2022 | -68.18% |
| Sep 30, 2022 | -89.05% |
| Jun 30, 2022 | -37.72% |